SCHEMBL2169766

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2169612	0.85	HSD11B1 (0.34)	HSD11B1TACR1
	SCHEMBL2170813	0.84	PTGS1 (0.38)	HSD11B1
	SCHEMBL2168703	0.83	P2RX7 (0.40)	HSD11B1
	SCHEMBL2169125	0.83	HSD11B1 (0.33)	HSD11B1
	SCHEMBL2168659	0.83	P2RX7 (0.34)	HCRTR2HSD11B1
	SCHEMBL2168978	0.83	EPHX2 (0.40)	HSD11B1
	SCHEMBL2170857	0.83	MEN1 (0.40)	HSD11B1BRD4TACR1
	SCHEMBL2169652	0.83	HSD11B1 (0.43)	HSD11B1
	SCHEMBL2168347	0.81	HSD17B10 (0.35)	HSD11B1
	SCHEMBL2170753	0.81	ACHE (0.40)	GRM2GRM3HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.